SCHEMBL15480692

SCHEMBL15480692

O=C(NCc1cccc(F)c1)Nc1csc(C2CCCCC2)c1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ ROCK2 O75116 2/20 0.45
▸ ROCK1 Q13464 1/20 0.45
▸ NAMPT P43490 1/20 0.44
▸ EPHX2 P34913 2/20 0.41
▸ LMNA P02545 3/20 0.41
▸ ATG4B Q9Y4P1 1/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ANPEP P15144 1/20 0.39
▸ EPHX1 P07099 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15241647 0.82 ROCK2 (0.45) ALDH1A1KDM4EL3MBTL1ROCK2ROCK1
SCHEMBL12831003 0.75 ROCK2 (0.48) ALDH1A1KDM4EL3MBTL1ROCK2ROCK1
SCHEMBL12830442 0.74 CYP2C19 (0.53) ALDH1A1KDM4EEPHX2RAB9AEPHX1
SCHEMBL12830920 0.70 TSHR (0.42) ALDH1A1KDM4EL3MBTL1LMNAMAPK1
SCHEMBL353107 0.68 ROCK1 (0.68) ROCK2ROCK1EPHX2ATG4B
SCHEMBL15258595 0.67 CASP3 (0.53) ROCK2ROCK1RAB9A
SCHEMBL14434568 0.67 LMNA (0.73) L3MBTL1ROCK2NAMPTEPHX2LMNA
SCHEMBL3509234 0.67 ROCK1 (0.56) ROCK2ROCK1NAMPTATG4B
SCHEMBL353616 0.66 ROCK2 (0.53) ROCK2ROCK1NAMPTEPHX2ATG4B
SCHEMBL10237503 0.66 ROCK1 (0.61) ROCK2ROCK1NAMPTATG4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885KDM4E 4057/4885L3MBTL1 3943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback